Checkpoint inhibitor immunotherapy induced inflammatory arthritis secondary to Nivolumab and Ipilimumab: a pediatric first

• मुख्य लेखकों: John A. Storwick (लेखक), Herman Tam (लेखक), Daniel G. Rosenbaum (लेखक), Kristin Houghton (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2024-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Immune checkpoint inhibitors (ICIs) have expanded the arsenal of cancer therapeutics over the last decade but are associated with a spectrum of immune-related adverse events (irAEs), including inflammatory arthritis. While these complications are increasingly recognized in the ad...